FIGURE 4.

Analysis of the immunological signature in plasma of advanced non‐small cell lung cancer (NSCLC) patients and study of the orientation of the innate response. (A) Study of the immunological signature in plasma of 41 patients by Luminex analysis. Higher levels of CXCL10 and lower levels of CCL17 were observed in responders compared to non‐responders. Results not significant after the Bonferroni correction. (B) Comparison of plasma levels of TGFβ and iNOS (not exploitable in Luminex) in responders and non‐responders by ELISA assay. Demonstration of a trend: responders with higher levels of iNOS. Significance code: .01 ‘*’; .05 ‘.’; .1 ‘n.s.’; 1: a, Welch test; b, Wilcoxon test